CAR-Engineered NK Cells Targeting Wild-Type EGFR and EGFRvIII Enhance Killing of Glioblastoma and Patient-Derived Glioblastoma Stem Cells

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Scientific Reports

Topics

Biology

Biochemistry

Cancer Oncology

Immunology

Cancer Research

Show all topics

DOI

10.1038/srep11483

License

CC-BY

Other Formats

PDF